Literature DB >> 20302995

Is major depression adequately diagnosed and treated by general practitioners? Results from an epidemiological study.

Anna Fernández1, Alejandra Pinto-Meza, Juan Angel Bellón, Pere Roura-Poch, Josep M Haro, Jaume Autonell, Diego José Palao, María Teresa Peñarrubia, Rita Fernández, Elena Blanco, Juan Vicente Luciano, Antoni Serrano-Blanco.   

Abstract

OBJECTIVES: The aim of this study was to (1) to explore the validity of the depression diagnosis made by the general practitioner (GP) and factors associated with it, (2) to estimate rates of treatment adequacy for depression and factors associated with it and (3) to study how rates of treatment adequacy vary when using different assessment methods and criteria.
METHODS: Epidemiological survey carried out in 77 primary care centres representative of Catalonia. A total of 3815 patients were assessed.
RESULTS: GPs identified 69 out of the 339 individuals who were diagnosed with a major depressive episode according to the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (sensitivity 0.22; kappa value: 0.16). The presence of emotional problems as the patients' primary complaint was associated with an increased probability of recognition. Rates of adequacy differed according to criteria: in the cases detected with the SCID-I interview, adequacy was 39.35% when using only patient self-reported data and 54.91% when taking into account data from the clinical chart. Rates of adequacy were higher when assessing adequacy among those considered depressed by the GP.
CONCLUSION: GPs adequately treat most of those whom they consider to be depressed. However, they fail to recognise depressed patients when compared to a psychiatric gold standard. Rates of treatment adequacy varied widely depending on the method used to assess them. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20302995     DOI: 10.1016/j.genhosppsych.2009.11.015

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  22 in total

1.  Predicting the future development of depression or PTSD after injury.

Authors:  Therese S Richmond; Josef Ruzek; Theimann Ackerson; Douglas J Wiebe; Flaura Winston; Nancy Kassam-Adams
Journal:  Gen Hosp Psychiatry       Date:  2011-06-15       Impact factor: 3.238

2.  Factors associated with duration of new antidepressant treatment: analysis of a large primary care database.

Authors:  Christopher Burton; Niall Anderson; Katie Wilde; Colin R Simpson
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

3.  Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).

Authors:  Maria Rubio-Valera; María Teresa Peñarrubia-María; Maria Iglesias-González; Martin Knapp; Paul McCrone; Marta Roig; Ramón Sabes-Figuera; Juan V Luciano; Juan M Mendive; Ana Gabriela Murrugara-Centurión; Jordi Alonso; Antoni Serrano-Blanco
Journal:  Eur J Health Econ       Date:  2019-02-06

4.  Combining the GP's assessment and the PHQ-9 questionnaire leads to more reliable and clinically relevant diagnoses in primary care.

Authors:  Clara Teusen; Alexander Hapfelmeier; Victoria von Schrottenberg; Feyza Gökce; Gabriele Pitschel-Walz; Peter Henningsen; Jochen Gensichen; Antonius Schneider
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

5.  Patterns of antidepressant use in Italy: therapy duration, adherence and switching.

Authors:  Luca Degli Esposti; Carlo Piccinni; Diego Sangiorgi; Andrea Fagiolini; Stefano Buda
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

6.  Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders.

Authors:  Elena Olariu; José-Ignacio Castro-Rodriguez; Pilar Álvarez; Carolina Garnier; Marta Reinoso; Luis Miguel Martín-López; Jordi Alonso; Carlos G Forero
Journal:  Qual Life Res       Date:  2014-10-04       Impact factor: 4.147

7.  Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).

Authors:  Maria Rubio-Valera; Imma Beneitez; María Teresa Peñarrubia-María; Juan V Luciano; Juan M Mendive; Paul McCrone; Martin Knapp; Ramon Sabés-Figuera; Katarzyna Kocyan; Javier García-Campayo; Antoni Serrano-Blanco
Journal:  BMC Psychiatry       Date:  2015-03-31       Impact factor: 3.630

8.  Primary care physicians' perspective on the management of anxiety and depressive disorders: a cross-sectional survey in Emilia Romagna Region.

Authors:  Federica Casini; Cecilia Sighinolfi; Paola Tedesco; Pier Venanzio Bandieri; Maria Bologna; Niccolò Colombini; Clara Curcetti; Michele Magnani; Mara Morini; Alberto Serio; Ilaria Tarricone; Domenico Berardi; Marco Menchetti
Journal:  BMC Fam Pract       Date:  2013-06-07       Impact factor: 2.497

9.  Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care.

Authors:  Antoni Sicras-Mainar; Jorge Maurino; Luis Cordero; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda
Journal:  Ann Gen Psychiatry       Date:  2012-08-03       Impact factor: 3.455

10.  Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment.

Authors:  Mauro Garcia-Toro; Esteban Medina; Jaime L Galan; Miguel A Gonzalez; Jorge Maurino
Journal:  BMC Psychiatry       Date:  2012-09-18       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.